The Medicines and Healthcare products Regulatory Agency (MHRA), in partnership with the Advertising Standards Authority (ASA) and General Pharmaceutical Council (GPhC), has this week jointly released an updated Enforcement Notice , to reiterate the rules around the advertising of prescription-only medicines (POMs) used for weight management.

The updated notice is directed at businesses, primarily pharmacies, that make these medicines available to the public and provides important clarity on the kinds of claims and images in an ad that are likely to break the rules.

Advertisers should avoid language that refers to POMs, such as “weight-loss injection”, “obesity treatment jab” or “GLP-1”, imagery likely to be understood by consumers as denoting a prescription medicine, and ads for genera

See Full Page